HDFC Pharma and Healthcare Fund - DIR
Sectoral
Current NAV
22.16
▼
0.03%
Year 1 Forecast
25.31
+14.2%
Year 2 Forecast
27.18
+22.7%
Fund at a Glance
Key information and performance summary
Key Metrics
AUM (Cr.)
76,567
Holdings
36
Risk
Very High
Funds in Category
14
Fund Return
1 Month
3.0%
3 Month
11.6%
1 Year
25.0%
3 Year
0.0%
Category Return
1 Month
3.4%
3 Month
9.9%
1 Year
9.2%
3 Year
11.3%
NAV Performance History
Asset Allocation
Latest Portfolio
2026-08-13
Equity
Cash
Top Holdings
| Company | Weight | Industry |
|---|---|---|
| Sun Pharmaceutical Industries | 10.0% | Pharma B2C |
| Divis Laboratories | 7.2% | Pharma APIs and CRAMS |
| Max Healthcare | 5.6% | Healthcare |
| Lupin Ltd | 5.3% | Pharma B2C |
Fund Narrative
AI-powered fund insights and portfolio commentary will be available here
Investment Thesis
This section will eventually be generated by the Vista Narrative Engine and will summarize the investment philosophy of the fund, portfolio positioning, key strengths, potential risks, and the suitability of the fund for different investor profiles.
🚀 Coming Soon